T. Rowe Price Associates
CCCC icon

T. Rowe Price Associates’s C4 Therapeutics CCCC Stock Holding History

T. Rowe Price Associates’s Portfolio CCCC Stock Details CCCC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$189K Buy
71,546
+59,146
+477% +$139K ﹤0.01% 2862
2025
Q4 		$24K Hold
12,400
– – ﹤0.01% 3075
2025
Q3 		$28K Hold
12,400
– – ﹤0.01% 3032
2025
Q2 		$18K Sell
12,400
-25,743
-67% -$37.4K ﹤0.01% 3048
2025
Q1 		$62K Hold
38,143
– – ﹤0.01% 2900
2024
Q4 		$138K Sell
38,143
-353,861
-90% -$1.76M ﹤0.01% 2783
2024
Q3 		$2.23M Buy
392,004
+329,697
+529% +$1.98M ﹤0.01% 1580
2024
Q2 		$288K Sell
62,307
-2,053,170
-97% -$12.2M ﹤0.01% 2437
2024
Q1 		$17.3M Sell
2,115,477
-443,003
-17% -$3.43M ﹤0.01% 1012
2023
Q4 		$14.5M Buy
2,558,480
+372,021
+17% +$848K ﹤0.01% 1025
2023
Q3 		$4.07M Sell
2,186,459
-642,146
-23% -$1.96M ﹤0.01% 1219
2023
Q2 		$7.78M Sell
2,828,605
-46,769
-2% -$150K ﹤0.01% 1108
2023
Q1 		$9.03M Sell
2,875,374
-49,879
-2% -$294K ﹤0.01% 1075
2022
Q4 		$17.3M Sell
2,925,253
-38,803
-1% -$322K ﹤0.01% 950
2022
Q3 		$26M Sell
2,964,056
-1,419,107
-32% -$14.7M ﹤0.01% 831
2022
Q2 		$33M Buy
4,383,163
+5,791
+0.1% +$51K ﹤0.01% 1013
2022
Q1 		$106M Buy
4,377,372
+292,574
+7% +$7.1M 0.01% 713
2021
Q4 		$132M Buy
4,084,798
+127,055
+3% +$5.02M 0.01% 680
2021
Q3 		$177M Buy
3,957,743
+412,906
+12% +$17.7M 0.02% 581
2021
Q2 		$134M Buy
3,544,837
+1,447,028
+69% +$51.8M 0.01% 682
2021
Q1 		$77.6M Buy
2,097,809
+567,767
+37% +$22.6M 0.01% 852
2020
Q4 		$49.4M Buy
+1,530,042
New +$44.4M 0.01% 970

Other funds holding CCCC

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return